Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus
Mycobacterium abscessus (Mab) is one of the most drug resistant bacteria with a high treatment failure rate. Antimicrobial peptides (AMPs) are alternative therapeutic agents against this infection. This study was aimed to assess the in vitro activities of thirteen AMPs (S5, S52, S6, S61, S62, S63, K...
| Główni autorzy: | , , , , , , |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
Public Library of Science (PLoS)
2021-01-01
|
| Seria: | PLoS ONE |
| Dostęp online: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592419/?tool=EBI |